Legal · +CLA · Search

Sortable EPCPCT correspondence table
The columns can be sorted by clicking on the column header.

* Page numbers in the English version of "Case Law of the Boards of Appeal of the European Patent Office", Sixth Edition, July 2010.

Links
Content EPC Articles EPC Rules EPC Guidelines BoA Decisions Pages*, Case Law PCT Articles PCT Rules PCT Guidelines

Novelty

54(2) / G-VI G2/88, G1/92,
G3/93, T
63-161 33(2) 33.1(a)-(b),
64.1-2
12

Novelty (conflicting)

54(3) 165 G-IV-5 G3/93, G1/03 65, 66, 68, 162,
262, 397
/ 33.1(c), 64.3,
70.10
11.07-11, 17.44

Novelty (first and
further medical use)

54(4)-(5) / G-VI-7.1 G2/08 133-152 / / /

Inventive step

56 / G-VII, F-II-4.1,
G-VII-Annex
T 162-222 33(3) / 13

Industrial application

57 / G-III, F-II-4.9 / 223-228 33(4) / 14

Clarity, support
(conciseness see: Claims)

84 43(1), (3) B-IV-1.1, F-IV-4,
F-IV-6, G-VI-6
T 251-270, 275-279 6 6.3(b) 5, 9.19-9.38

Disclosure

83, 100(b) / F-III G2/93, T 229-251 5 / 4.02, 4.06, 4.12

Amendments
(see also: Error
correction and Priority)

123(2)-(3),
76(1), 100(c)
137, 161 H, C-IV-5 & 6,
C-III-2, C-V-4,
B-III-3.3, A-V-2.2
G2/88, G1/93,
G1/99, G1/03,
G1/05, G2/10
315-374 19*, 34(2)(b)
* claims only, not descr.
66.3-4 20.10

Error correction

/ 139, 140 H-VI, H-VI-4.2.1 G3/89, G2/95,
G8/95, G1/10
342-344, 369-374,
394, 395
/ 91, 66.4bis 8, 15.30

Description, Content (cite
prior art, provide example, etc.)

/ 42(1)(a)-(f) F-II-4, H-V-2 / 170, 225, 232,
299, 345
/ 5.1(a)(i)-(vi) 4.03-10

Description, Structure

/ 42(2) F-II-4.10 / / / 5.1(b) /

Claims (definitions in
terms of technical features)

/ 43(1) / / 251, 263, 273-274 / 6.3(a) /

Claims (conciseness)

84 43(2), 62a F-IV-3.2 & 3,
F-IV-5
/ 270-273 6 6.1(a) 5.42, A5.42[1],
A5.42[2]

Claims
(dependent claims)

/ 43(4) F-IV-3.4 & 5 & 6 / / / 6.4(a)-(c) /

Claims
(reasonable number)

/ 43(5) / / / / 6.1(a)-(b) /

Claims
(no reference to description)

/ 43(6) F-IV-4.17 / / / 6.2(a) /

Claims
(reference signs)

/ 43(7) F-IV-4.19 / / / 6.2(b) /

Drawings
(no text in drawings)

/ 46(2)(j) F-II-5.1 / / / 11.11 /

Unity

82 44, 64,
164
B-III-3.12, B-VII,
B-XI-5, F-V,
DOI: 10.1016/
j.wpi.2007.10.008
,
DOI: 10.1016/
j.wpi.2009.01.002
G1/91, G2/92 292-314 17(3), 34(3) 13.1-3, 40,
66.1(e)
10

Incomplete search

/ 62a, 63 B-VIII, F-III-1,
F-IV-4.1, F-IV-5,
F-IV-6.3, C-IV-7.2,
DOI: 10.1016/
j.wpi.2006.10.011
,
DOI: 10.1016/
j.wpi.2009.01.002
/ 670, 671, 835 17(2), 34(4) / 9, 15.22, 15.29,
15.62, 16.17-16.19,
16.25-16.29,
17.29-17.35

Patentability

52(1), 100(a) / G-I-1 / 1-10 / / /

Patentability (exclusions)

52(2)-(3) / G-II-3 G3/08 10-35 / 67.1 9.02-15

Patentability (exceptions:
public order, morality)

53(a) 48 F-II-7, G-II-4 G2/06 36-42 / 9.1 15.31

Patentability (exceptions:
plant or animal varieties,
methods for treatment)

53(b)-(c) / G-II-4 G1/98, G1/07,
G1/08
36, 37, 42-63 / 67.1 9.02-15

Priority

87, 88, 89 52, 53, 54,
59, 70b, 141
B-VI-3, B-VI-4.1,
B-VI-4.2, G-IV-3,
F-VI
G3/93, G2/98 397-423 8, Art. 4C.(4),
Paris Conv.
4.10, 17,
43bis.1, 64.1,
70.10
6.07-10

Divisional applications

76 36 A-IV-1, C-IV-1 G4/98, G1/05,
G1/06, G1/09
375-395 / / /

Oral proceedings

116 4, 115,
116, 124
E-II, H-III-2.1.3 G2/94, G4/95 453-477 / 66.6 19.31-36,
3.21, 19.21

Right to be heard

113(1),
114(2)
/ E-IX-1.2, C-IV-3,
E-II-8.6, E-IX-5
G4/92, G8/91,
G2/04
438-453 34(2) 40.2(c)-(e),
66.3-6
3.16,
10.66-70,
19.20-21,
19.31-6

Grant or Refusal

97 71(3) C-V G10/93 679, 680 / / /

SI Units

/ 49(10) F-II-4.13,
F-II-Annex-2
/ 700 / 10.1(a)-(e) /

Formal issues
(related: Role of patent fees, 2010)

/ 46, 49 A-III, document
category: B-X-9.2
/ / / 11 /

Biological material
deposition

/ 31 / G2/93 243, 244 / 13bis /

Non-prejudicial disclosures

55 / / G3/98 68, 69, 562 / / /

Rights conferred,
Extent of protection

64(1), 69 / / G2/88 111, 361, 362, 698,
825, 247, 251, 279,
281-283
/ / /